series-a
Stage
About
Cytospire develops next-generation multispecific antibodies that engage γδ T cells to create safer and more targeted cancer immunotherapies.
Explore Cytospire's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.